Pharmaceutical industry
Pfizer Inc., the world's largest pharmaceutical company, is facing increasing scrutiny over its Bextra and Celebrex drugs. The company has reported receiving requests for information and documents from the U.S. Department of Justice and a group of attorneys general, including Connecticut Attorney General Richard Blumenthal. The requests
Microsoft Corp.
The pharmaceutical giant Pfizer and technology powerhouse Microsoft have launched a coordinated effort to tackle the growing issue of international spam rings selling counterfeit versions of Pfizer's Viagra. The joint strategy, announced on Thursday, involves 17 legal actions targeting spammers and pharmacy Web-site operators across the globe. The
Pharmaceutical industry
Pfizer Inc., a major pharmaceutical company, has seen its shares drop over 15 percent in the last week following research findings that its popular drug Celebrex increases the risk of heart attack. Analysts predict a significant decline in Pfizer's sales, from $51.1 billion in 2004 to $46.
Pharmaceutical industry
The maker of the arthritis pain reliever Celebrex, Pfizer, is rethinking how it markets the drug after a study showed high doses are linked to a higher risk of heart attack. The company has spent a significant amount of money promoting Celebrex, including $70 million in the first nine months
Pharmaceutical industry
Thousands of Canadians who rely on painkillers have been left in medical limbo after the world's biggest drug maker warned that Celebrex, a popular arthritis medication, may pose serious safety risks. The issue has sparked growing concern that the new class of anti-inflammatory medications known as cox-2 inhibitors
Pharmaceutical industry
The popular arthritis drug Celebrex has raised safety concerns after a study showed patients taking the medication were at a higher risk of heart and blood vessel problems compared to those taking a placebo. This news comes just 10 weeks after Merck pulled its similar drug, Vioxx, off the market
Pharmaceutical industry
A group of women from the Monsanto Women's Golf Club have formed a tight-knit community, despite the changes in the company they work for. The club, which has been in existence for 42 years, has seen its membership drop from 100 to 25 due to layoffs, retirements, and
Pharmaceutical industry
The U.S. Food and Drug Administration has approved Lipitor, a cholesterol-lowering therapy developed by Pfizer, Inc., for the prevention of cardiovascular disease in patients with normal-to-mildly elevated cholesterol levels who have other cardiovascular risk factors. The approval is based on the findings of the ASCOT trial, which demonstrated that
Pharmaceutical industry
Patients with type-2 diabetes taking Pfizer's cholesterol-lowering medicine, Lipitor, have a 37% reduction in major cardiovascular events and a 48% lower risk of strokes compared to those receiving a placebo, according to the largest study on statins in this patient population. The Collaborative Atorvastatin Diabetes Study (CARDS) involved
Pharmaceutical industry
Paradigm Genetics, Inc. announced the appointment of Peter G. Tombros to its board of directors, bringing valuable expertise in the pharmaceutical sector to the company. Tombros, chairman and CEO of VivoQuest, a combinatorial chemistry company, joins the board along with Doug Morton, who was recently appointed. This move reflects the
Pharmaceutical industry
NPR recently reported that Pfizer, the world's largest drug company, has agreed to pay $430 million in fines for its former subsidiary Warner-Lambert's aggressive marketing of the drug Neurontin for unapproved uses. Despite being approved by the FDA in 1993 to treat epileptic seizures, Warner-Lambert promoted
Pharmaceutical industry
As drug companies face increasing competition and rising out-of-pocket costs for patients, two major pharmaceutical giants, Pfizer and Novartis, are adopting innovative marketing strategies to attract customers directly. By offering free trials, rebates, and refunds, they are taking cues from other industries that have successfully marketed to consumers. The promotion
